Daraprim
Daraprim is a medicine authorised by Swissmedic under authorisation number 20964. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 February 1955 and the authorisation is valid without a time limit. ATC code P01BD01 places the medicine in the group Antiprotozoals.
| Authorisation number | 20964 |
|---|---|
| Name | Daraprim |
| Full name | Daraprim, Tabletten |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | P01BD01 |
| First authorisation | 22 February 1955 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Daraprim, Tabletten | B | 22 February 1955 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | P01BD01 | 08.04.3. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Daraprim authorised in Switzerland?
Yes. Daraprim is authorised by Swissmedic under authorisation number 20964, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Daraprim have?
Daraprim is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Daraprim?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.